Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience

被引：0
|
作者：
Ghamsari, Farid [1 ]
Trando, Aaron [2 ]
Medley, Katherine [3 ]
Martino, Janine [3 ]
Block, Shanna [3 ]
Wells, Kaitlyn [3 ]
Doan, Thu [3 ]
Quach, Anthony [3 ]
Cheng, Renee [4 ]
Costello, Caitlin [1 ]
Jeong, Autumn [5 ]
Saunders, Ila [6 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] UCSD Sch Med, San Diego, CA USA
[3] UCSD Hlth, Dept Pharm, San Diego, CA USA
[4] UCSD Hematol Oncol Fellowship Program, San Diego, CA USA
[5] UCSD Div Blood & Bone Marrow Transplantat, San Diego, CA USA
[6] UCSD Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-025
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
    Habib, Alma
    Khan, Abdullah Mohammad
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Shaikh, Hira
    Strouse, Christopher
    Green, Kimberly M.
    Davis, James A.
    Hashmi, Hamza
    Snyder, Jordan
    Mahmoudjafari, Zahra
    Mushtaq, Muhammad Umair
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Atrash, Shebli
    Paul, Barry
    Friend, Reed
    BLOOD, 2024, 144 : 7037 - 7038
  • [32] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [33] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma
    Becnel, Melody
    Ferreri, Christopher
    Feng, Lei
    Richards, Tiffany
    Horowitz, Sandra
    Patel, Nimisha
    Gombos, Dan
    Razmandi, Azadeh
    Murga, Astrid
    Seif, Sherif
    Youssef, George
    Murphy, Kevin
    Kaufman, Gregory
    Weber, Donna
    Patel, Krina
    Thomas, Sheeba
    Manasanch, Elisabet
    Orlowski, Robert
    Lee, Hans
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S163 - S164
  • [34] Real-world experience of KPD use in relapsed or refractory myeloma
    Barrett, A.
    Gul, F.
    Nee, A.
    O'Leary, H.
    O'Keefe, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 238 - 238
  • [35] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
  • [36] A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Dileo, Rachel
    Mewawalla, Prerna
    Babu, Kalaivani
    Yin, Yue
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [37] The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone
    Nakayama, Hitomi
    Aisa, Yoshinobu
    Ito, Chisako
    Sakurai, Aki
    Nakazato, Tomonori
    HEMATOLOGY REPORTS, 2024, 16 (04) : 593 - 602
  • [38] Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel M.
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew J.
    Sperling, Adam S.
    Anderson Jr, Larry D.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [39] BCMA x CD3 bispecific antibody treatment with teclistamab in relapsed and/or refractory multiple myeloma: a real-world monocentric analysis
    Schaefers, C.
    Thiele, B.
    Alsdorf, W.
    Kosch, R.
    Leypoldt, L.
    Bokemeyer, C.
    Weisel, K.
    Kamili, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 312 - 312
  • [40] Real World Evaluation of Teclistamab: A Focus on Infections in Patients With Relapsed Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Martin, Thomas
    Wolf, Jeffrey
    Chung, Alfred
    Arora, Shagun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S536 - S537
12345